• Channels
    • All News
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Health Tech
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Nikkei Biotechnology
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • Editorial Standards
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Pfiz­er inks deal to snatch Abzena's new North Car­oli­na man­u­fac­tur­ing site

3 years ago
Manufacturing

CMS ini­ti­ates cov­er­age analy­sis for provider-ad­min­is­tered PrEP to pre­vent HIV

3 years ago
Pharma

FDA of­fers new draft guid­ance on can­cer drug dose op­ti­miza­tion with over­haul of max­i­mum tol­er­at­ed dose par­a­digm

3 years ago
FDA+

PwC pre­dicts 'flur­ry' of $5B to $15B biotech deals in 2023

3 years ago
Deals
Pharma

Biden’s chief sci­ence of­fi­cer for Covid-19 steps down amid dearth of top lead­er­ship

3 years ago
FDA+

Drug name re­view: Sci­ence takes the spot­light in 2022

3 years ago
Pharma
Marketing

Aeter­na dis­con­tin­ues vac­cine de­vel­op­ment; Idera re­brands as Ac­er­a­gen

3 years ago
News Briefing

Pfiz­er shifts full port­fo­lio to non-prof­it mod­el in 45 low­er-in­come coun­tries

3 years ago
Pharma

Fol­low­ing Alzheimer’s drug ap­proval, an­a­lysts dish on what they ex­pect from Bio­gen in 2023 

3 years ago
Pharma

Mar­ket­ingRx roundup: Eli Lil­ly de­buts un­brand­ed ‘mem­o­ry’ is­sues TV ad; Big Phar­mas amp so­cial me­dia spend­ing

3 years ago
Pharma
Marketing

Leap Ther­a­peu­tics jumps in­to grow­ing Claudin18.2 field by buy­ing Flame Bio­sciences

3 years ago
Financing
Startups

NewAms­ter­dam notch­es an­oth­er win in res­ur­rec­tion of Am­gen car­dio drug

3 years ago
R&D

Ab­b­Vie, Eli Lil­ly quit UK's vol­un­tary drug pric­ing agree­ment, send­ing 'warn­ing sig­nal' to UK gov­ern­ment

3 years ago
Pharma

Can­cer vac­cine de­vel­op­er jumps to Nas­daq via re­verse merg­er

3 years ago
Deals

Lat­est news on Covid boost­ers safe­ty sig­nal; As­traZeneca leads trio of M&A; The biggest news out of #JPM23; and more

3 years ago
Weekly

US in­ves­ti­gates po­ten­tial safe­ty sig­nal with Pfiz­er Covid boost­ers

3 years ago
Pharma
FDA+

Cal­i­for­nia sues in­sulin heavy­weights, PBMs over 'ex­ces­sive' prices

3 years ago
Pharma
Law

Ex-Take­da staffer­'s 's­mall hus­tle' ends with ar­rest and $2.3M fraud scheme charge

3 years ago
Pharma
Law

EMA de­vel­op­ing physi­cian guid­ance for po­ten­tial liv­er dam­age af­ter tak­ing Zol­gens­ma

3 years ago
Pharma
Cell/Gene Tx

My­ovant, Pfiz­er de­but first brand­ed cam­paign for prostate can­cer med Or­govyx

3 years ago
Pharma
Marketing

Most trust­ed: Phar­ma over­takes tech in­dus­try for top spot in Ip­sos’ an­nu­al trust­wor­thi­ness sur­vey

3 years ago
Pharma
Marketing

Scoop: Roche-backed start­up gives up on CD47, lays off all em­ploy­ees

3 years ago
People
Startups

In ‘clever’ ex­per­i­ment, sci­en­tists use gene edit­ing to treat heart dis­ease in mice

3 years ago
R&D
Discovery

No­vo Nordisk's GLP-1 for Type II di­a­betes ap­proved for first-line treat­ment

3 years ago
FDA+
First page Previous page 390391392393394395396 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Health Tech
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Nikkei Biotechnology
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • Editorial Standards
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints News 2025

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
FT Specialist Logo
A service from the Financial Times
Endpoints News

Log in to your account

email

password

Endpoints News

request login link

Enter the email associated to with your Endpoints account, and we'll send you a one-time login link (no password needed). The link expires after 24 hours.

email

Endpoints News

reset password

Enter the email associated to with your Endpoints account, and we'll send you a link to reset your password. The link expires after 24 hours and can only be used once.

email

Endpoints News

Sign up for free to read a limited number of articles each month.

About You

Newsletter Interests

Pick what newsletters get delivered to your inbox each week.

Biopharma

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 3:30 PM ET

BREAKING NEWS ALERTS 2-3 times a week

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET

POST-HOC 1-2 times a week

Healthcare

ENDPOINTS HEALTH TECH Tuesday, Thursday at 10 AM ET

BREAKING NEWS ALERTS 2-3 times a week

Want unlimited access? Sign up for a premium subscription plan.